Société Générale


SG's earnings recovery gains legs as the execution of the strategic plan unfolds

15/04/24 -"We now factor a stronger recovery into our 2024 (+16%) and 2025 (+15%) EPS projections as we see a higher prospect of recovery for SG. Our 2024 upgrade comes on the back of higher revenue (+2%), ..."

Pages
77
Language
English
Published on
15/04/24
You may also be interested by these reports :
17/11/25
As its name suggests, Swiss Life (REDUCE ; Switzerland) focuses on pensions and savings – it is in fact one of the few pure (or almost pure) plays in ...

14/11/25
Two months ago, we looked at Investor performance under Trump II. Since Trump’s election, Industrivärden (ADD; Sweden) has followed a very similar ...

13/11/25
KBC delivered another quarter of accelerating earnings momentum, with upgrades to 2025 guidance supported by broad-based growth, strict cost control, ...

13/11/25
The third quarter results were barely on track with expectations on an underlying basis. This looks disappointing following peers’ strong results, ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO